Latham & Watkins and Beccar Varela advised Skydance and the Investor Group on the transaction; Sullivan & Cromwell advised RedBird Capital Partners; Ropes & Gray advised...
Paramount’s $28 Billion Merger Agreement with Skydance
Viatris’ Global Research and Development Collaboration with Idorsia
Cravath Swaine & Moore is representing Viatris in the transaction. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Idorsia Ltd (SIX: IDIA) announced they have entered...
Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics
Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
Technip Energies’ Launch of Reju
Cravath Swaine & Moore represented IBM in the transaction. Technip Energies (PARIS: TE) (ISIN:NL0014559478) announced the launch of Reju, a new company focused on PET (Polyethylene terephthalate)...
Proximus’ Acquisition of a Majority Stake in Route Mobile
Cravath, alongside Slaughter and May, AZB & Partners and NautaDutilh, is representing Route Mobile and its founding shareholders in connection with the transaction. On July 17,...
IBM’s Acquisition of Polar Security
Cravath represented IBM in connection with the transaction. IBM announced it has acquired Polar Security, an innovator in technology that helps companies discover, continuously monitor and...
Disney’s Proxy Contest With Trian Fund
Cravath represented Disney in the transaction. The Walt Disney Company (“Disney”) issued a statement in response to Nelson Peltz’s announcement that Trian Fund is no longer...
IBM’s Acquisition of Octo
Cravath represented IBM in connection with the transaction while Morrison Foerster served as government contracts and regulatory counsel to Octo. IBM announced an agreement to acquire...
Viatris’ Acquisition of Famy Life Sciences
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
Apollo-Led Consortium’s Acquisition of Atlas Air
Cravath, Swaine & Moore advised Atlas Air Worldwide, Paul, Weiss, Rifkind, Wharton & Garrison advised Apollo and the Consortium entity, and Jones Day advised J.F. Lehman...
IBM’s Acquisition of Randori
Cravath represented IBM in the transaction. IBM announced it plans to acquire Randori, a leading attack surface management and offensive cybersecurity provider. Recognized as a leader...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...